Standout Papers

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. 1997 2026 2006 2016 523
  1. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. (1997)
    W ten Bokkel Huinink, Martin Gore et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 14 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
1 intermediate paper

Works of N. Davidson being referenced

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
2010
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
1997 Standout

Author Peers

Author Last Decade Papers Cites
N. Davidson 1274 348 264 491 430 41 1.9k
Patrick Berteloot 713 337 352 443 795 84 1.9k
D. Fennelly 1729 551 374 865 260 85 2.5k
Hans‐Joachim Lück 1833 559 705 385 681 66 2.8k
Michela Donadio 1073 323 526 247 83 66 1.8k
Timothy W. Jacobs 1104 253 736 487 64 49 2.4k
H. Hausmaninger 1317 236 893 203 99 53 2.1k
Ping Yang 1104 380 236 279 117 26 1.6k
Victoria M. Chia 659 170 212 405 326 36 1.6k
B. Fisher 724 568 110 349 104 29 1.5k
J. Cuzick 955 245 560 260 178 39 1.6k

All Works

Loading papers...

Rankless by CCL
2026